Ovarian Cancer Screening

This screening service uses a venous blood sample to assess CA‑125, a protein that may be elevated in ovarian cancer and related conditions. In the same appointment, a pelvic ultrasound scans the ovaries, womb and surrounding pelvis, providing visual context to the blood result. The test is designed for women 40 years and older, especially those with a known family history or previous ovarian concerns. Results are delivered after the scan, typically within a few days, and include a detailed report plus a clinician consultation to explain the findings. By pairing a single biomarker with imaging, the service aims to give a more comprehensive early‑warning picture than either method alone.